Target intelligence / Profile preview

Zinc finger MYND domain-containing protein 10 (ZMYND10)

Target
ZMYND10
Molecular classification
Other (zinc finger protein, specifically MYND-type), Dynein assembly factor, Protein coding gene
01

Overview

Zinc finger MYND domain-containing protein 10 (ZMYND10) is a cytoplasmic protein that plays a critical role in the assembly and function of motile cilia. It acts as a co-chaperone in a protein complex that assists in the pre-assembly and stabilization of dynein arms—core molecular structures needed for the movement of cilia. Specifically, ZMYND10 interacts with other assembly factors (such as LRRC6, FKBP8, and HSP90) and is essential for axonemal (the ciliary “skeleton”) organization and motility[1][2][3][4][6]. Mutations in ZMYND10 disrupt dynein arm formation, leading to the inherited disorder **primary ciliary dyskinesia (PCD)**, characterized by defective ciliary movement and a spectrum of clinical symptoms including chronic respiratory tract infections and defects in left-right body asymmetry[2][3][5][6]. ZMYND10 is also recognized as a tumor suppressor gene, frequently altered in certain cancers[6]. There are currently no known drug interactions or therapies precisely targeting ZMYND10.

Other names
BLULUCA12.4CILD22DNAAF7Protein BLuDynein axonemal assembly factor 7Tumor suppressor BLUFLU
02

Biological functions

Assembly and stabilization of dynein arms for motile ciliaAxonemal structure organizationCiliary motility regulationActs as co-chaperone for protein complex assemblyTumor suppression (potential role)
03

Disease associations

Ciliary dyskinesia, primary (notably type 22)Primary ciliary dyskinesia (PCD)Cancer (as a tumor suppressor gene, often inactivated in various cancers)
04

Safety considerations

Loss-of-function mutations lead to primary ciliary dyskinesia (immotile cilia, respiratory disease, hydrocephalus, laterality defects)Deletion or silencing in cancer may affect response to therapies; full clinical implications under investigation
05

Biomarkers

Mutations in ZMYND10 (used in genetic diagnosis of PCD and research for some cancers)

Beyond the preview

Go deeper on Zinc finger MYND domain-containing protein 10 (ZMYND10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger MYND domain-containing protein 10 (ZMYND10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call